Osteoporosis Drug Fosamax Linked To Femur Fractures; Did Merck Fail To Warn Of Risks?

Merck & Company’s osteoporosis drug Fosamax has been linked to debilitating femur (thigh bone) fractures and femur injuries when taken for more than five years. Although the U.S. Food & Drug Administration (FDA) notified Merck about increased reports of fractures, the pharmaceutical giant waited nearly a year and a half to respond’ putting Fosamax drug users at increased risk of injury.

→ Read More

Fosamax Trials Set

Three early trials regarding Merck & Company’s osteoporosis drug, Fosamax, have been set for trial. Fosamax users have been diagnosed with osteonecrosis of the jaw, an irreversible and painful condition that destroys bone tissue and hundreds of lawsuits have been filed against the pharmaceutical giant.

→ Read More